Pages that link to "Q39905428"

The following pages link to Alterations in CIITA constitute a common mechanism accounting for downregulation of MHC class II expression in diffuse large B-cell lymphoma (DLBCL). (Q39905428):

Displaying 19 items.

• Joint network and node selection for pathway-based genomic data analysis (Q30643757) (← links)
• HLA dependent immune escape mechanisms in B-cell lymphomas: Implications for immune checkpoint inhibitor therapy? (Q33632104) (← links)
• Decreased major histocompatibility complex class II expression in diffuse large B-cell lymphoma does not correlate with CpG methylation of class II transactivator promoters III and IV. (Q34334683) (← links)
• Genome-wide detection of genes targeted by non-Ig somatic hypermutation in lymphoma (Q34341934) (← links)
• Molecular classification, pathway addiction, and therapeutic targeting in diffuse large B cell lymphoma (Q35797583) (← links)
• Genetic lesions in diffuse large B-cell lymphomas (Q35974341) (← links)
• Biological prognostic markers in diffuse large B-cell lymphoma (Q38019791) (← links)
• Histone deacetylase inhibitors activate CIITA and MHC class II antigen expression in diffuse large B-cell lymphoma (Q39136897) (← links)
• DNA methylation dysregulates and silences the HLA-DQ locus by altering chromatin architecture (Q39591021) (← links)
• Coordinate loss of MHC class II expression in the diffuse large B cell lymphoma cell line OCI-Ly2 is due to a novel mutation in RFX-AP. (Q39760951) (← links)
• HLA-G and MHC Class II Protein Expression in Diffuse Large B-Cell Lymphoma (Q41050317) (← links)
• Tumor-associated macrophages in diffuse large B-cell lymphoma (Q42940545) (← links)
• Class II major histocompatibility complex expression and cell size independently predict survival in canine B-cell lymphoma (Q47364919) (← links)
• Immune Escape Mechanisms in Diffuse Large B-Cell Lymphoma (Q58690185) (← links)
• Germinal center-derived lymphomas: The darkest side of humoral immunity (Q64087351) (← links)
• Dysfunction of antigen processing and presentation by dendritic cells in cancer (Q88301302) (← links)
• Genomic Analyses Identify Recurrent Alterations in Immune Evasion Genes in Diffuse Large B-Cell Lymphoma, Leg Type (Q88950581) (← links)
• Hide or defend, the two strategies of lymphoma immune evasion: potential implications for immunotherapy (Q90101887) (← links)
• Evolving insights into the genomic complexity and immune landscape of diffuse large B-cell lymphoma: opportunities for novel biomarkers (Q97070219) (← links)